Protocol for a systematic review of the diagnostic and prognostic utility of tests currently available for the detection of aspirin resistance in patients with established cardiovascular or cerebrovascular disease. (2013)
Attributed to:
Midland Hub for Trials Methodology Research at University of Birmingham
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/2046-4053-2-16
PubMed Identifier: 23442317
Publication URI: http://europepmc.org/abstract/MED/23442317
Type: Journal Article/Review
Volume: 2
Parent Publication: Systematic reviews
ISSN: 2046-4053